Smith Michael David 4
4 · KalVista Pharmaceuticals, Inc. · Filed May 19, 2022
Insider Transaction Report
Form 4
Smith Michael David
Sr. VP, Development
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-05-17+10,320→ 10,320 totalExercise: $9.28Exp: 2032-05-16→ Common Stock (10,320 underlying) - Award
Restricted Stock Units
2022-05-17+15,480→ 15,480 total→ Common Stock (15,480 underlying)
Footnotes (3)
- [F1]The option vests over a 4 year period: 1/48th on June 17,2022, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F3]1/16th of the total RSUs subject to the Award shall vest on each quarterly anniversary of the Vesting Commencement Date thereafter, subject to continued service through each vesting date.